ATC
TEVA icon

Adirondack Trust Company’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Adirondack Trust Company’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-200
Closed -$2K – 443
2021
Q3 		$2K Sell
200
-134
-40% -$1.25K ﹤0.01% 392
2021
Q2 		$3K Hold
334
– – ﹤0.01% 373
2021
Q1 		$4K Hold
334
– – ﹤0.01% 354
2020
Q4 		$4K Sell
334
-134
-29% -$1.28K ﹤0.01% 332
2020
Q3 		$4K Hold
468
– – ﹤0.01% 298
2020
Q2 		$5K Hold
468
– – ﹤0.01% 290
2020
Q1 		$4K Hold
468
– – ﹤0.01% 291
2019
Q4 		$5K Hold
468
– – ﹤0.01% 299
2019
Q3 		$3K Hold
468
– – ﹤0.01% 327
2019
Q2 		$4K Hold
468
– – ﹤0.01% 318
2019
Q1 		$7K Hold
468
– – ﹤0.01% 270
2018
Q4 		$7K Hold
468
– – 0.01% 262
2018
Q3 		$10K Hold
468
– – 0.01% 260
2018
Q2 		$11K Hold
468
– – 0.01% 241
2018
Q1 		$8K Hold
468
– – 0.01% 263
2017
Q4 		$9K Buy
468
+200
+75% +$3.01K 0.01% 248
2017
Q3 		$5K Hold
268
– – ﹤0.01% 271
2017
Q2 		$9K Sell
268
-56
-17% -$1.73K 0.01% 248
2017
Q1 		$10K Buy
324
+56
+21% +$1.91K 0.01% 249
2016
Q4 		$10K Sell
268
-90
-25% -$3.59K 0.01% 245
2016
Q3 		$16K Hold
358
– – 0.01% 216
2016
Q2 		$18K Hold
358
– – 0.01% 237
2016
Q1 		$19K Hold
358
– – 0.01% 215
2015
Q4 		$22K Hold
358
– – 0.02% 199
2015
Q3 		$20K Hold
358
– – 0.02% 202
2015
Q2 		$21K Hold
358
– – 0.02% 207
2015
Q1 		$22K Hold
358
– – 0.02% 208
2014
Q4 		$21K Hold
358
– – 0.02% 212
2014
Q3 		$19K Hold
358
– – 0.01% 218
2014
Q2 		$19K Hold
358
– – 0.01% 216
2014
Q1 		$19K Hold
358
– – 0.02% 201
2013
Q4 		$14K Sell
358
-310
-46% -$12.2K 0.01% 207
2013
Q3 		$25K Hold
668
– – 0.02% 171
2013
Q2 		$26K Buy
+668
New +$26K 0.02% 154

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Adirondack Trust Company's TEVA Position: Q4 2021 in Review

Adirondack Trust Company sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2021, closing a stake of 200 shares — an estimated $2K sold.

Adirondack Trust Company first reported a position in TEVA in Q2 2013 and held it in 34 quarters. The position peaked at $26K in Q2 2013. 450 funds tracked by Wall St. Rank hold TEVA as of Q4 2021.

  • Adirondack Trust Company reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2021 after selling out during the quarter.
  • Adirondack Trust Company sold 200 Teva Pharmaceutical Industries Limited shares in Q4 2021, an estimated $2K.
  • Adirondack Trust Company first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and held it in 34 quarters.
  • Adirondack Trust Company's Teva Pharmaceutical Industries Limited position peaked at $26K in Q2 2013.
  • 450 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2021.

Based on Adirondack Trust Company's 13F filing for Q4 2021, filed 13 Jan 2022.